Literature DB >> 33690663

Ventilator-associated pneumonia among ICU patients in WHO Southeast Asian region: A systematic review.

Sanjeev Kharel1, Anil Bist1, Shyam Kumar Mishra2.   

Abstract

Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections and a leading cause of death among patients in Intensive Care Unit (ICU). The South East Asian Region is a part of the world with limited health resources where infectious diseases are still underestimated. We aimed to review the literature in this part of the world to describe incidence, mortality and microbiological evidence of VAP and explore preventive and control strategies. We selected 24 peer-reviewed articles published from January 1, 2000 to September 1, 2020 from electronic databases and manual searching for observational studies among adult patients diagnosed with VAP expressed per thousand days admitted in ICU. The VAP rates ranged from 2.13 to 116 per thousand days, varying among different countries of this region. A significant rate of mortality was observed in 13 studies ranging from 16.2% to 74.1%. Gram negative organisms like Acinetobacter spp., Pseudomonas aeruginosa and Klebsiella pneumoniae and Gram-positive organisms like Staphylococcus aureus and Enterococcus species were frequently found. Our findings suggest an alarming situation of VAP among patients of most of the countries of this region with increasing incidence, mortality and antibiotic resistance. Thus, there is an urgent need for cost effective control and preventive measures like interventional studies and educational programs on staff training, hand hygiene, awareness on antibiotic resistance, implementation of antibiotic stewardship programs and appropriate use of ventilator bundle approach.

Entities:  

Year:  2021        PMID: 33690663     DOI: 10.1371/journal.pone.0247832

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  6 in total

1.  Nutritional Status Disorders and Selected Risk Factors of Ventilator-Associated Pneumonia (VAP) in Patients Treated in the Intensive Care Ward-A Retrospective Study.

Authors:  Lucyna Ścisło; Elżbieta Walewska; Iwona Bodys-Cupak; Agnieszka Gniadek; Maria Kózka
Journal:  Int J Environ Res Public Health       Date:  2022-01-05       Impact factor: 3.390

2.  Effect of modified care bundle for prevention of ventilator-associated pneumonia in critically-ill neurosurgical patients.

Authors:  Suphannee Triamvisit; Wassana Wongprasert; Chalermwoot Puttima; Matchima Na Chiangmai; Nawaphan Thienjindakul; Laksika Rodkul; Chumpon Jetjumnong
Journal:  Acute Crit Care       Date:  2021-11-23

Review 3.  A Narrative Review on the Approach to Antimicrobial Use in Ventilated Patients with Multidrug Resistant Organisms in Respiratory Samples-To Treat or Not to Treat? That Is the Question.

Authors:  Lowell Ling; Wai-Tat Wong; Jeffrey Lipman; Gavin Matthew Joynt
Journal:  Antibiotics (Basel)       Date:  2022-03-27

4.  Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii.

Authors:  Dalia Adukauskiene; Ausra Ciginskiene; Agne Adukauskaite; Despoina Koulenti; Jordi Rello
Journal:  Antibiotics (Basel)       Date:  2022-07-04

5.  Biofilm Formation by Pathogens Causing Ventilator-Associated Pneumonia at Intensive Care Units in a Tertiary Care Hospital: An Armor for Refuge.

Authors:  Sujata Baidya; Sangita Sharma; Shyam Kumar Mishra; Hari Prasad Kattel; Keshab Parajuli; Jeevan Bahadur Sherchand
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411

6.  Genetic Diversity, Antimicrobial Resistance Pattern, and Biofilm Formation in Klebsiella pneumoniae Isolated from Patients with Coronavirus Disease 2019 (COVID-19) and Ventilator-Associated Pneumonia.

Authors:  Asma Ghanizadeh; Maede Najafizade; Somaye Rashki; Zeynab Marzhoseyni; Mitra Motallebi
Journal:  Biomed Res Int       Date:  2021-12-24       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.